John M. Evans

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
By: /s/ Christine Bellon, Attorney-in-fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John M. Evans

Form 4 holding CEO, Director

Beam Therapeutics Inc.

Security class
Stock Option (Right to Buy)
Shares / value
18,672
Estimated value
$3,782,000
Report date
31 Mar 2026
Price
$24.40
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Verve Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
15,500
Estimated value
Report date
09 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John M. Evans

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .